The Federal Trade Commission (FTC) is questioning Amgen’s $27.8 billion acquisit...
Healthcare startup Hippocratic AI has emerged with $50 million in funding to dev...
UniQure made an announcement that it has sold a portion of the royalties worth $...
The FDA announced on Friday that a new non-hormonal medication, Veozah, also kno...
IntraOp Medical Corporation has announced the second phase of the first-ever Ele...
Amid the difficulties of the biotech market at present, investors are inclined t...
Two months after partnering with Novartis for its radio-conjugates, UK-based Bic...
Gilead has acquired a San Diego start-up for early-stage cancer and immune drugs...
Eyenovia Inc. – an ophthalmic technology firm setting up the Optejet equipment f...
The FDA has raised concerns publicly following inspections of Eli Lilly and Rent...
Enzolytics, Inc., made an announcement recently that its wholly-owned subsidiary...
It is unclear if the first gene therapy for Duchenne muscular dystrophy will be ...
Pfizer and Valneva are delaying the regulatory filing of their Lyme disease vacc...
A study was published in the Proceedings of the National Academy of Sciences exp...
Travere Therapeutics is a startup that mainly focuses on rare forms of diseases....
Johnson & Johnson’s Janssen Biotech subsidiary has just paid $245 million upfron...
